CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $424 | -54.3% | 86,444 | +0.1% | 0.00% | -50.0% |
Q4 2022 | $927 | -99.9% | 86,344 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $808,000 | +12.8% | 86,344 | +10.1% | 0.00% | 0.0% |
Q2 2022 | $716,000 | +24.7% | 78,444 | +66.0% | 0.00% | +100.0% |
Q1 2022 | $574,000 | +64.0% | 47,244 | +64.4% | 0.00% | 0.0% |
Q4 2021 | $350,000 | +73.3% | 28,744 | +120.4% | 0.00% | – |
Q3 2021 | $202,000 | -16.5% | 13,044 | -23.0% | 0.00% | -100.0% |
Q2 2021 | $242,000 | – | 16,944 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,702,110 | $439,144 | 0.04% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,935,718 | $499,415 | 0.01% |
ADAR1 Capital Management, LLC | 159,469 | $41,143 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 414,731 | $107,001 | 0.01% |
FARALLON CAPITAL MANAGEMENT LLC | 1,556,251 | $401,513 | 0.00% |
Virtu Financial LLC | 75,987 | $20 | 0.00% |
Corsair Capital Management | 19,864 | $5,125 | 0.00% |
WEALTH EFFECTS LLC | 13,500 | $3,483 | 0.00% |
Cypress Capital Management LLC (WY) | 5,000 | $1,290 | 0.00% |
Citadel Advisors | 5,000 | $1,290 | 0.00% |